Pages that link to "Q46698848"
Jump to navigation
Jump to search
The following pages link to Early oxidative damage underlying neurodegeneration in X-adrenoleukodystrophy (Q46698848):
Displaying 50 items.
- ATP-binding cassette, sub-family D (ALD), member 1 (Q14912816) (← links)
- The role of ELOVL1 in very long-chain fatty acid homeostasis and X-linked adrenoleukodystrophy (Q24300003) (← links)
- Current and future pharmacological treatment strategies in X-linked adrenoleukodystrophy (Q24618949) (← links)
- Peroxisomes in brain development and function (Q26774697) (← links)
- Redox interplay between mitochondria and peroxisomes (Q28394944) (← links)
- Functional Characterization of IPSC-Derived Brain Cells as a Model for X-Linked Adrenoleukodystrophy (Q28551048) (← links)
- C26:0-Carnitine Is a New Biomarker for X-Linked Adrenoleukodystrophy in Mice and Man (Q28551663) (← links)
- X-linked adrenoleukodystrophy (X-ALD): clinical presentation and guidelines for diagnosis, follow-up and management. (Q30460666) (← links)
- Oxidative stress and adrenocortical insufficiency (Q33709973) (← links)
- Very long-chain fatty acid accumulation causes lipotoxic response via 5-lipoxygenase in cerebral adrenoleukodystrophy (Q33902055) (← links)
- Dicer ablation in oligodendrocytes provokes neuronal impairment in mice (Q33910494) (← links)
- Abcd2 is a strong modifier of the metabolic impairments in peritoneal macrophages of ABCD1-deficient mice (Q34257373) (← links)
- Pathophysiology of X-linked adrenoleukodystrophy (Q34390414) (← links)
- Pathomechanisms underlying X-adrenoleukodystrophy: a three-hit hypothesis. (Q34491978) (← links)
- Antioxidants halt axonal degeneration in a mouse model of X-adrenoleukodystrophy. (Q34631169) (← links)
- Peroxisomal dysfunction in inflammatory childhood white matter disorders: an unexpected contributor to neuropathology (Q34801173) (← links)
- Histone deacetylase inhibitor upregulates peroxisomal fatty acid oxidation and inhibits apoptotic cell death in abcd1-deficient glial cells (Q34907267) (← links)
- Autophagy induction halts axonal degeneration in a mouse model of X-adrenoleukodystrophy. (Q35092638) (← links)
- Oxidative damage compromises energy metabolism in the axonal degeneration mouse model of X-adrenoleukodystrophy (Q35193956) (← links)
- HDAC inhibitor SAHA normalizes the levels of VLCFAs in human skin fibroblasts from X-ALD patients and downregulates the expression of proinflammatory cytokines in Abcd1/2-silenced mouse astrocytes (Q35380239) (← links)
- ABCD1 deletion-induced mitochondrial dysfunction is corrected by SAHA: implication for adrenoleukodystrophy (Q35417932) (← links)
- Functional genomic analysis unravels a metabolic-inflammatory interplay in adrenoleukodystrophy (Q35750216) (← links)
- Preferential expression of mutant ABCD1 allele is common in adrenoleukodystrophy female carriers but unrelated to clinical symptoms (Q35818334) (← links)
- Pioglitazone halts axonal degeneration in a mouse model of X-linked adrenoleukodystrophy (Q35997389) (← links)
- Partial rescue of Rett syndrome by ω-3 polyunsaturated fatty acids (PUFAs) oil (Q36049510) (← links)
- Induction of mitochondrial changes associated with oxidative stress on very long chain fatty acids (C22:0, C24:0, or C26:0)-treated human neuronal cells (SK-NB-E). (Q36167749) (← links)
- Activation of sirtuin 1 as therapy for the peroxisomal disease adrenoleukodystrophy. (Q36288305) (← links)
- Oxidative stress modulates mitochondrial failure and cyclophilin D function in X-linked adrenoleukodystrophy (Q36474703) (← links)
- Brain endothelial dysfunction in cerebral adrenoleukodystrophy (Q36515946) (← links)
- The gene expression profiles of induced pluripotent stem cells from individuals with childhood cerebral adrenoleukodystrophy are consistent with proposed mechanisms of pathogenesis (Q36632900) (← links)
- Caffeic acid phenethyl ester induces adrenoleukodystrophy (Abcd2) gene in human X-ALD fibroblasts and inhibits the proinflammatory response in Abcd1/2 silenced mouse primary astrocytes (Q36713344) (← links)
- Plasmalogen deficiency in cerebral adrenoleukodystrophy and its modulation by lovastatin (Q36953948) (← links)
- Glutathione imbalance in patients with X-linked adrenoleukodystrophy (Q37066947) (← links)
- Oxidative imbalance in nonstimulated X-adrenoleukodystrophy-derived lymphoblasts (Q37347171) (← links)
- Myelin proteomics: molecular anatomy of an insulating sheath (Q37378722) (← links)
- Peroxisomes, myelination, and axonal integrity in the CNS. (Q37576855) (← links)
- Tauroursodeoxycholic bile acid arrests axonal degeneration by inhibiting the unfolded protein response in X-linked adrenoleukodystrophy (Q37596791) (← links)
- Myelin lesions associated with lysosomal and peroxisomal disorders (Q37785556) (← links)
- Adrenoleukodystrophy in female heterozygotes: underrecognized and undertreated (Q37960281) (← links)
- The peroxisome: an update on mysteries (Q37993383) (← links)
- Mitochondrial sirtuins--a new therapeutic target for repair and protection in multiple sclerosis (Q38019568) (← links)
- Mitochondrial dysfunction in central nervous system white matter disorders (Q38215315) (← links)
- X-linked adrenoleukodystrophy: pathogenesis and treatment. (Q38239213) (← links)
- Peroxisome-mitochondria interplay and disease. (Q38357539) (← links)
- Oxidative Stress in Patients with X-Linked Adrenoleukodystrophy (Q38546277) (← links)
- A Thyroid Hormone-Based Strategy for Correcting the Biochemical Abnormality in X-Linked Adrenoleukodystrophy. (Q38716382) (← links)
- Antioxidant Capacity and Superoxide Dismutase Activity in Adrenoleukodystrophy (Q38746580) (← links)
- Adrenoleukodystrophy - neuroendocrine pathogenesis and redefinition of natural history (Q38867787) (← links)
- Adenoassociated virus serotype 9-mediated gene therapy for x-linked adrenoleukodystrophy (Q38919524) (← links)
- Mechanisms of Antioxidant Induction with High-Dose N-Acetylcysteine in Childhood Cerebral Adrenoleukodystrophy (Q40209375) (← links)